MMP-9 may modulate target genes associated with inflammation and immune responses via transcription factor activation, and the small-molecule drugs identified could serve as a significant strategy for inhibiting MMP-9, thereby providing a scientific rationale for clinical interventions in H. pylori and IBD. This evidence concerns the gene MMP9 and inflammatory bowel disease.